Quantum Biopharma (QNTM) Shares Outstanding (2019 - 2026)

Quantum Biopharma (QNTM) reported Shares Outstanding (Entity) of $917.8 million for Q3 2024, up 43.2% sequentially from $641.0 million in Q2 2024.

Quantum Biopharma (QNTM) Shares Outstanding (2019 - 2026) Analysis & Trends

Quantum Biopharma (QNTM) has 3 years of Shares Outstanding (Entity) data on file, last reported at $917.8 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6,012.74 Bn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 400.00 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 62.06 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Quantum Biopharma 13.00 Bn 13.00 Bn - 4.49 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.49 Bn
Dec 31, 2025 3.29 Mn
Sep 30, 2025 3.80 Bn
Jun 30, 2025 3.02 Bn
Mar 31, 2025 2.47 Bn
Dec 31, 2024 1.14 Mn
Sep 30, 2024 917.85 Mn
Jun 30, 2024 640.97 Mn
Mar 31, 2024 609.85 Mn
Dec 31, 2023 609,056.00
Sep 30, 2023 6,460.00
Jun 30, 2023 5,998.00
Mar 31, 2023 599.24 Mn
Dec 31, 2022 595,704.00
Sep 30, 2022 8,151.00
Jun 30, 2022 5,229.00
Mar 31, 2022 537,457.00
Dec 31, 2021 537,457.00
Sep 30, 2021 12,919.00
Jun 30, 2021 10,766.00